Biotechnology

BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program

VANCOUVER, BC, March 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into an agreement with Bioanalytical Systems, Inc. d...

2021-03-18 20:09 4527

Microba Life Sciences appoints experienced executive Mark Capone to the Board

BRISBANE, Australia, March 18, 2021 /PRNewswire/ -- Microba Life Sciences  has appointed international executive, Mark Capone, as a Non-Executive Director of the Board, bringing with him more than 35 years of experience in the life sciences sector. Mr Capone spent 17 ...

2021-03-18 12:49 4003

Epredia And Paige Announce Global Commercial Distribution Agreement For Digital Pathology Software

PORTSMOUTH, N.H., March 17, 2021 /PRNewswire/ -- Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in pathology, have announced today that they have entered into a commercial distribution agreement for Paige's comprehensive portfo...

2021-03-18 01:02 1623

Biobohemia Released Paper on the Discovery of the Antigenic Essence of Cancer Cells

BOSTON, March 17, 2021 /PRNewswire/ -- Scientists announced today that they have discovered why they have not succeeded in developing a vaccine against cancer. Vaccination is a powerful tool that has helped us cope with many dangerous diseases, and it is an effective means of combatting the curre...

2021-03-17 20:00 1492

111, Inc. Enters into First-Ever Strategic Partnership with BeiGene

SHANGHAI, March 17, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, announced today it has entered into a strategic cooperation agreem...

2021-03-17 18:50 4569

GenScript and G42 Healthcare announce collaboration to provide innovative solutions to fight against COVID-19

SINGAPORE, March 17, 2021 /PRNewswire/ -- GenScript Biotech Singapore, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world leading biotechnology company, and G42 Healthcare, a leading healthcare technology company, based in the UAE, today announced they have ...

2021-03-17 17:23 4022

Transcenta Continues to Push the Boundary of Cell Culture Productivity by Achieving > 6 g/L PER Day Volumetric Productivity in Continuous Perfusion Platform

SUZHOU and HANGZHOU, China, March 16, 2021 /PRNewswire/ -- Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced a major breakthrough in its continuous perfusion cell culture p...

2021-03-17 08:00 1582

GenScript receives "Best Contract Research Organization Award" in the 4th Annual Asia-Pacific Bioprocessing Excellence Awards Ceremony 2021

SINGAPORE, March 16, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) receives the "Best Contract Research Organization Award" on the 4th Annual Asia Pacific Bioprocessing Excellence Awards Ceremony 2021held on 16th March 2021. The award follows GenScri...

2021-03-16 20:57 4079

VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update

AUSTIN, Texas, March 16, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, March 23, at 8:00 a.m. Eastern time to discuss its financial and operating results for the full fiscal year 2020, in addition to providing ...

2021-03-16 20:30 5387

QBiotics Welcomes TDM Growth Partners As Cornerstone Investor in a Capital Raise To Accelerate Drug Development Timelines

Key highlights: * QBiotics welcomes TDM Growth Partners as cornerstone investor * TDM Growth Partners is investing A$50 million into QBiotics to accelerate QBiotics' human drug development pipeline, support marketing of the company's veterinary pharmaceutical STELFONTA® and strengthen the QBi...

2021-03-16 06:35 2642

Microba Life Sciences partners with Unilever to target sleep through the gut microbiome

BRISBANE, Australia, March 15, 2021 /PRNewswire/ -- Experts in gut microbiome analysis, Microba Life Sciences , is empowering global consumer goods companyUnilever  to take a novel approach to this problem by exploring the links between sleep...

2021-03-15 21:59 2975

BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs

VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...

2021-03-15 20:00 3025

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...

2021-03-15 19:00 3182

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...

2021-03-15 19:00 5073

Antengene Included in the Shenzhen-Hong Kong Stock Connect

SHANGHAI and HONG KONG, March 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and o...

2021-03-15 09:40 3484

Antengene Appoints Minyoung Kim as General Manager of Antengene South Korea

SHANGHAI and SEOUL, South Korea, March 15, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematolo...

2021-03-15 08:00 3652

Medeze Commended by Frost & Sullivan for Dominating the Stem Cell Banking Market with Its Pioneering, Full Spectrum Services

Medeze's expansion strategies and customer-focused innovation in MSC banks and regenerative therapies have enabled it to garner a major share of the market SINGAPORE, March 12, 2021 /PRNewswire/ -- Based on its recent analysis of the Southeast Asia stem cell banking market, Frost & Sullivan recog...

2021-03-12 17:55 3770

Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines

SHANGHAI, March 11, 2021 /PRNewswire/ -- Delonix Bioworks Ltd. (Delonix), a biotechnology company dedicated to developing the next generation vaccines with synthetic biology approaches, has recently closed a$14 million Series Seed financing led by Boehringer Ingelheim Venture Fund (BIVF) and IDG ...

2021-03-11 21:21 1649

PharmAbcine to Present at AACR Annual Meeting 2021

DAEJEON, South Korea, March 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today an e-posterpresentation featuring nonclinical data of PMC-309 at American Association for Cancer Researc...

2021-03-11 21:00 1453

Kintor Pharmaceutical Announces Results from Investigator-Initiated Brazil Trial Demonstrating 92% Reduction in Mortality in Hospitalized COVID-19 Patients

SUZHOU, China, March 11, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939), a clinical-stage biotechnology company developing small molecule and biological therapeutics, announced today top-line results from its investigator-initiated Brazil trial evaluating the efficacy of Proxalut...

2021-03-11 14:54 4834
1 ... 253254255256257258259 ... 306

Week's Top Stories